Baxter International, Inc. (BAX)
19.11
-0.19
(-0.98%)
USD |
NYSE |
Dec 31, 16:00
19.12
+0.01
(+0.05%)
After-Hours: 20:00
Baxter International Research and Development Expense (TTM): 518.00M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Boston Scientific Corp. | 1.943B |
| Becton, Dickinson & Co. | 1.264B |
| iRhythm Technologies, Inc. | 82.64M |
| Insulet Corp. | 270.80M |
| Tandem Diabetes Care, Inc. | 198.42M |